Participants discussed the outcomes of the joint cross analysis on medtechs written by advisory partner CEA. They also exchanged on business models of research and innovation infrastructures to identify key success factors and risks. 

Then they had the opportunity to visit the bio mechanical laboratory from CETIM, where implants ‘resistance is tested before CE approval.